Suppr超能文献

CRISPR-Cas9 介导的毕赤酵母基因组多位点整合。

CRISPR-Cas9-mediated genomic multiloci integration in Pichia pastoris.

机构信息

State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, 130 Meilong Road, Shanghai, 200237, China.

Chinare Resources Angde Biotech Pharmaceutical Co., Ltd., 78 E-jiao Street, Liaocheng, China.

出版信息

Microb Cell Fact. 2019 Aug 21;18(1):144. doi: 10.1186/s12934-019-1194-x.

Abstract

BACKGROUND

Pichia pastoris (syn. Komagataella phaffii) is a widely used generally recognized as safe host for heterologous expression of proteins in both industry and academia. Recently, it has been shown to be a potentially good chassis host for the production of high-value pharmaceuticals and chemicals. Nevertheless, limited availability of selective markers and low efficiency of homologous recombination make this process difficult and time-consuming, particularly in the case of multistep biosynthetic pathways. Therefore, it is crucial to develop an efficient and marker-free multiloci gene knock-in method in P. pastoris.

RESULTS

A non-homologous-end-joining defective strain (Δku70) was first constructed using the CRISPR-Cas9 based gene deficiency approach. It was then used as a parent strain for multiloci gene integration. Ten guide RNA (gRNA) targets were designed within 100 bp upstream of the promoters or downstream of terminator, and then tested using an eGFP reporter and confirmed as suitable single-locus integration sites. Three high-efficiency gRNA targets (PUP-g2, PUP-g1, and PUP-g1) were selected for double- and triple-locus co-integration. The integration efficiency ranged from 57.7 to 70% and 12.5 to 32.1% for double-locus and triple-locus integration, respectively. In addition, biosynthetic pathways of 6-methylsalicylic acid and 3-methylcatechol were successfully assembled using the developed method by one-step integration of functional genes. The desired products were obtained, which further established the effectiveness and applicability of the developed CRISPR-Cas9-mediated gene co-integration method in P. pastoris.

CONCLUSIONS

A CRISPR-Cas9-mediated multiloci gene integration method was developed with efficient gRNA targets in P. pastoris. Using this method, multiple gene cassettes can be simultaneously integrated into the genome without employing selective markers. The multiloci integration strategy is beneficial for pathway assembly of complicated pharmaceuticals and chemicals expressed in P. pastoris.

摘要

背景

巴斯德毕赤酵母(又名汉逊毕赤酵母)是一种广泛应用于工业和学术界的蛋白质异源表达的通用安全宿主。最近,它已被证明是生产高价值药物和化学品的潜在良好底盘宿主。然而,选择标记的有限可用性和同源重组的低效率使得这个过程变得困难和耗时,特别是在多步生物合成途径的情况下。因此,开发一种在巴斯德毕赤酵母中高效且无标记的多位点基因敲入方法至关重要。

结果

首先使用基于 CRISPR-Cas9 的基因缺失方法构建了一个非非同源末端连接缺陷株(Δku70)。然后,它被用作多基因整合的亲本菌株。在启动子上游 100bp 或终止子下游设计了 10 个向导 RNA(gRNA)靶点,然后使用 eGFP 报告基因进行测试,并被证实为合适的单基因整合位点。选择三个高效 gRNA 靶点(PUP-g2、PUP-g1 和 PUP-g1)用于双基因和三基因共整合。双基因和三基因共整合的整合效率分别为 57.7%至 70%和 12.5%至 32.1%。此外,通过一步整合功能基因,成功地利用该方法组装了 6-甲基水杨酸和 3-甲基儿茶酚的生物合成途径。获得了所需的产物,进一步证实了所开发的 CRISPR-Cas9 介导的基因共整合方法在巴斯德毕赤酵母中的有效性和适用性。

结论

在巴斯德毕赤酵母中开发了一种基于 CRISPR-Cas9 的多位点基因整合方法,具有高效的 gRNA 靶点。使用该方法,可以在不使用选择标记的情况下,将多个基因盒同时整合到基因组中。多位点整合策略有利于在巴斯德毕赤酵母中表达复杂药物和化学品的途径组装。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd1d/6704636/5d2e330e4f46/12934_2019_1194_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验